litlas
Log inCreate account

Jeffrey R. Marks

Active 1987–2026

125
Papers
22,341
Citations
80
h-index
107
i10-index

Citations

Citations per year for Jeffrey R. Marks1963: 3 citations1980: 1 citations1988: 2 citations1989: 1 citations1990: 1 citations1991: 7 citations1992: 51 citations1993: 68 citations1994: 73 citations1995: 70 citations1996: 58 citations1997: 103 citations1998: 71 citations1999: 94 citations2000: 89 citations2001: 117 citations2002: 120 citations2003: 171 citations2004: 228 citations2005: 208 citations2006: 203 citations2007: 271 citations2008: 276 citations2009: 277 citations2010: 295 citations2011: 230 citations2012: 224 citations2013: 183 citations2014: 179 citations2015: 151 citations2016: 175 citations2017: 192 citations2018: 212 citations2019: 599 citations2020: 646 citations2021: 607 citations2022: 484 citations2023: 380 citations2024: 510 citations2025: 233 citations2026: 16 citations1964–1979: no citations, so these years are not shown1981–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,442 citing papers, 32.7% of this breakdownChina: 1,357 citing papers, 12.9% of this breakdownUnited Kingdom: 627 citing papers, 5.9% of this breakdownGermany: 440 citing papers, 4.2% of this breakdownItaly: 389 citing papers, 3.7% of this breakdownCanada: 342 citing papers, 3.2% of this breakdownFrance: 283 citing papers, 2.7% of this breakdownJapan: 263 citing papers, 2.5% of this breakdownAustralia: 245 citing papers, 2.3% of this breakdownNetherlands: 235 citing papers, 2.2% of this breakdownIndia: 227 citing papers, 2.2% of this breakdownSpain: 211 citing papers, 2% of this breakdown
0%32.7%Other 23.5%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology57.6%
  • Medicine31.2%
  • Computer Science4.5%
  • Immunology and Microbiology2.2%
  • Neuroscience0.9%
  • Engineering0.9%
  • Other2.7%

Topics

  • Gene expression and cancer classification3.9%
  • Cancer-related molecular mechanisms research3%
  • Breast Cancer Treatment Studies3%
  • Cancer-related Molecular Pathways2.8%
  • Cancer Genomics and Diagnostics2.8%
  • Epigenetics and DNA Methylation2.7%
  • Other81.8%

Coauthors

All papers

Open in search
  1. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

    Authors: Giovanni Ciriello, Michael L. Gatza, Andrew H. Beck, Matthew D. Wilkerson, Suhn K. Rhie, Alessandro Pastore, Hailei Zhang, Michael D. McLellan, Christina Yau, Cyriac Kandoth, Reanne Bowlby, Hui Shen, Sikander Hayat, Robert J. Fieldhouse, Susan C. Lester, Gary M. Tse, Rachel E. Factor, Laura C. Collins, Kimberly H. Allison, Yunn-Yi Chen, Kristin C. Jensen, Nicole B. Johnson, Steffi Oesterreich, Gordon B. Mills, Andrew D. Cherniack, Gordon Robertson, Christopher C. Benz, Chris Sander, Peter W. Laird, Katherine A. Hoadley, Tari A. King, Charles M. Perou, Rehan Akbani, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Thomas Barr, Andrew H. Beck, Christopher C. Benz, Stephen C. Benz, Mario Berríos, Rameen Beroukhim, Tom Bodenheimer, Lori Boice, Lori Boice, Jay Bowen, Reanne Bowlby, Denise Brooks, Andrew D. Cherniack, Lynda Chin, Juok Cho, Sudha Chudamani, Giovanni Ciriello, Tanja M. Davidsen, John A. Demchok, Jennifer B. Dennison, Li Ding, Ina Felau, Martin L. Ferguson, Scott Frazer, Stacey Gabriel, Jianjiong Gao, Julie M. Gastier-Foster, Michael L. Gatza, Nils Gehlenborg, Mark Gerken, Gad Getz, William J. Gibson, D. Neil Hayes, David I. Heiman, Katherine A. Hoadley, Andrea Holbrook, Robert A. Holt, Alan P. Hoyle, Hai Hu, Mei Huang, Carolyn M. Hutter, E. Shelley Hwang, E. Shelley Hwang, Steven J.M. Jones, Zhenlin Ju, Jaegil Kim, Phillip H. Lai, Peter W. Laird, Michael S. Lawrence, Kristen M. Leraas, Tara M. Lichtenberg, Pei Lin, Shiyun Ling, Jia Liu, Wenbin Liu, Laxmi Lolla, Yiling Lu, Yussanne Ma, Dennis T. Maglinte, Elaine R. Mardis, Jeffrey R. Marks, Marco A. Marra, Cynthia McAllister, Michael D. McLellan and 60 more - Cell 2015 cited by 1,981

  2. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma

    Authors: Tyler Risom, David R. Glass, Inna Averbukh, Candace C. Liu, Alex Baranski, Adam Kagel, Erin McCaffrey, Noah F. Greenwald, Belén Rivero‐Gutiérrez, Siri H. Strand, Sushama Varma, Alex Kong, Leeat Keren, Sucheta Srivastava, Chunfang Zhu, Zumana Khair, Deborah J. Veis, Katherine DeSchryver, Sujay Vennam, Carlo C. Maley, E. Shelley Hwang, Jeffrey R. Marks, Sean C. Bendall, Graham A. Colditz, Robert B. West, Michael Angelo - Cell 2022 cited by 395

  3. Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

    Authors: Qingsong Hu, Youqiong Ye, Li-Chuan Chan, Yajuan Li, Ke Liang, Aifu Lin, Sergey D. Egranov, Yaohua Zhang, Weiya Xia, Jing Gong, Yinghong Pan, Sujash S. Chatterjee, Jun Yao, Kurt W. Evans, Tina K. Nguyen, Peter K. Park, Jiewei Liu, Cristian Coarfa, Sri Ramya Donepudi, Vasanta Putluri, Nagireddy Putluri, Arun Sreekumar, Chandrashekar R. Ambati, David H. Hawke, Jeffrey R. Marks, Preethi H. Gunaratne, Abigail S. Caudle, Ayşegül A. Şahin, Gabriel N. Hortobágyi, Funda Meric‐Bernstam, Lieping Chen, Dihua Yu, Mien‐Chie Hung, Michael A. Curran, Leng Han, Chunru Lin, Liuqing Yang - Nature Immunology 2019 cited by 369

  4. LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism

    Authors: Xin Zheng, Han Han, Guang‐Ping Liu, Yanxiu Ma, Ruolang Pan, Lingjie Sang, Rui‐Hua Li, Luo-jia Yang, Jeffrey R. Marks, Wenqi Wang, Aifu Lin - The EMBO Journal 2017 cited by 187

  5. Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion

    Authors: Cheng‐Cao Sun, Youqiong Ye, Zhi Tan, Yuan Liu, Yajuan Li, Wei Hu, Ke Liang, Sergey D. Egranov, Lisa A. Huang, Zhao Zhang, Yaohua Zhang, Jun Yao, Tina K. Nguyen, Zilong Zhao, Andrew Wu, Jeffrey R. Marks, Abigail S. Caudle, Ayşegül A. Şahin, Jianjun Gao, Seth T. Gammon, David Piwnica‐Worms, Jian Hu, Paul J. Chiao, Dihua Yu, Mien‐Chie Hung, Michael A. Curran, George A. Călin, Haoqiang Ying, Leng Han, Chunru Lin, Liuqing Yang - Science Advances 2023 cited by 58

  6. The LINK-A lncRNA interacts with PtdIns(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors

    Authors: Aifu Lin, Qingsong Hu, Chunlai Li, Zhen Xing, Guolin Ma, Cheng Wang, Jun Li, Ye Yin, Jun Yao, Ke Liang, Shouyu Wang, Peter K. Park, Jeffrey R. Marks, Yan Zhou, Jianwei Zhou, Mien‐Chie Hung, Han Liang, Zhibin Hu, Hongbing Shen, David H. Hawke, Leng Han, Yubin Zhou, Chunru Lin, Liuqing Yang - Nature Cell Biology 2017 cited by 269

  7. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set

    Authors: Elizabeth Hope Cain, Ashirbani Saha, Michael R. Harowicz, Jeffrey R. Marks, P. Kelly Marcom, Maciej A. Mazurowski - Breast Cancer Research and Treatment 2018 cited by 198

  8. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts

    Authors: Siri H. Strand, Belén Rivero‐Gutiérrez, Kathleen E. Houlahan, José A. Seoane, Lorraine King, Tyler Risom, Lunden Simpson, Sujay Vennam, Aziz Khan, Luis Cisneros, Timothy Hardman, Bryan Harmon, Fergus J. Couch, Kristalyn K. Gallagher, Mark Kilgore, Wei Shi, Angela DeMichele, Tari A. King, Priscilla F. McAuliffe, Julie R. Nangia, Joanna Lee, Jennifer F. Tseng, Anna Maria Storniolo, Alastair M. Thompson, Gaorav P. Gupta, Robyn Burns, Deborah J. Veis, Katherine DeSchryver, Chunfang Zhu, Magdalena Matusiak, Jason Wang, Shirley Zhu, Jen Tappenden, Daisy Yi Ding, Dadong Zhang, Jingqin Luo, Shu Jiang, Sushama Varma, Lauren Anderson, Cody Straub, Sucheta Srivastava, Christina Curtis, Rob Tibshirani, Robert Michael Angelo, Allison Hall, Kouros Owzar, Kornélia Polyák, Carlo C. Maley, Jeffrey R. Marks, Graham A. Colditz, E. Shelley Hwang, Robert B. West - Cancer Cell 2022 cited by 88

  9. Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression

    Authors: Carey K. Anders, David S. Hsu, Gloria Broadwater, Chaitanya R. Acharya, John A. Foekens, Yi Zhang, Yixin Wang, P. Kelly Marcom, Jeffrey R. Marks, Phillip G. Febbo, Joseph R. Nevins, Anil Potti, Kimberly Blackwell - Journal of Clinical Oncology 2008 cited by 913

  10. LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling

    Authors: Lingjie Sang, Huai‐Qiang Ju, Guangping Liu, Tian Tian, Guolin Ma, Yun‐Xin Lu, Zexian Liu, Ruolang Pan, Ruihua Li, Hai‐long Piao, Jeffrey R. Marks, Luo-jia Yang, Qingfeng Yan, Wenqi Wang, Jian‐Zhong Shao, Yubin Zhou, Tianhua Zhou, Aifu Lin - Molecular Cell 2018 cited by 185

  11. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

    Authors: Esther H. Lips, Tapsi Kumar, Anargyros Megalios, Lindy L. Visser, Michael Sheinman, Angelo Fortunato, Vandna Shah, Marlous Hoogstraat, Emi Sei, Diego Mallo, Maria Roman-Escorza, Ahmed A. Ahmed, Mingchu Xu, Alexandra W. van den Belt‐Dusebout, Wim Brugman, Tod D. Casasent, Karen Clements, Helen Davies, Liping Fu, Anita Grigoriadis, Timothy Hardman, Lorraine King, Marielle Krete, Petra Kristel, Michiel de Maaker, Carlo C. Maley, Jeffrey R. Marks, Brian A. Menegaz, Lennart Mulder, Frank Nieboer, Salpie Nowinski, Sarah E. Pinder, Jelmar Quist, Carolina Salinas-Souza, Michael Schaapveld, Marjanka K. Schmidt, Abeer M. Shaaban, Rana Shami, Mathini Sridharan, John H. Zhang, Hilary Stobart, Deborah Collyar, Serena Nik‐Zainal, Lodewyk F.A. Wessels, E. Shelley Hwang, Nicholas E. Navin, P. Andrew Futreal, P. Andrew Futreal, E. Shelley Hwang, Jos Jonkers, Jacco, Fariba Behbod, Daniel Rea, Proteeti Bhattacharjee, Donna Pinto, Ellen Verschuur, Marja van Oirsouw, Alastair M. Thompson, Jelle Wesseling, Elinor J. Sawyer - Nature Genetics 2022 cited by 92

  12. JAK2-binding long noncoding RNA promotes breast cancer brain metastasis

    Authors: Shouyu Wang, Ke Liang, Qingsong Hu, Ping Li, Jian H. Song, Yuedong Yang, Jun Yao, Lingegowda S. Mangala, Chunlai Li, Wenhao Yang, Peter K. Park, David H. Hawke, Jianwei Zhou, Yan Zhou, Weiya Xia, Mien‐Chie Hung, Jeffrey R. Marks, Gary E. Gallick, Gabriel Lopez‐Berestein, Elsa R. Flores, Anil K. Sood, Suyun Huang, Dihua Yu, Liuqing Yang, Chunru Lin - Journal of Clinical Investigation 2017 cited by 231

  13. A joint analysis of metabolomics and genetics of breast cancer

    Authors: Xiaohu Tang, Chao‐Chieh Lin, Ivan Spasojević, Edwin S. Iversen, Jen‐Tsan Chi, Jeffrey R. Marks - Breast Cancer Research 2014 cited by 209

  14. Archival single-cell genomics reveals persistent subclones during DCIS progression

    Authors: Kaile Wang, Tapsi Kumar, Junke Wang, Darlan Conterno Minussi, Emi Sei, Jianzhuo Li, Tuan M. Tran, Aatish Thennavan, Min Hu, Tod D. Casasent, Zhenna Xiao, Shanshan Bai, Lei Yang, Lorraine King, Vandna Shah, Petra Kristel, Carolien L. van der Borden, Jeffrey R. Marks, Yuehui Zhao, Amado J. Zurita, Ana M. Aparicio, Brian F. Chapin, Jie Ye, Jianjun Zhang, Don L. Gibbons, Ellinor Sawyer, Alastair M. Thompson, P. Andrew Futreal, Esther Hwang, Jelle Wesseling, Esther H. Lips, Nicholas E. Navin - Cell 2023 cited by 55

  15. Predicting the clinical status of human breast cancer by using gene expression profiles

    Authors: Mike West, Carrie Blanchette, Holly K. Dressman, Erich Huang, Seiichi Ishida, Rainer Spang, Harry Zuzan, John A. Olson, Jeffrey R. Marks, Joseph R. Nevins - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 1,341

  16. Glycosylation of KEAP1 links nutrient sensing to redox stress signaling

    Authors: Po‐Han Chen, Timothy J. Smith, Jianli Wu, Priscila F. Siesser, Brittany J. Bisnett, Farhan Mohammad Khan, Maxwell Hogue, Erik J. Soderblom, Flora Tang, Jeffrey R. Marks, Michael B. Major, Benjamin M. Swarts, Michael Boyce, Jen‐Tsan Chi - The EMBO Journal 2017 cited by 105

  17. Oncogenic pathway signatures in human cancers as a guide to targeted therapies

    Authors: Andrea Bild, Guang Yao, Jeffrey T. Chang, Quanli Wang, Anil Potti, Dawn A. D. Chasse, M. Joshi, David Harpole, Johnathan M. Lancaster, Andrew Berchuck, John A. Olson, Jeffrey R. Marks, Holly K. Dressman, Mike West, Joseph R. Nevins - Nature 2005 cited by 2,079

  18. The type III TGF-β receptor suppresses breast cancer progression

    Authors: Mei Dong, Tam How, Kellye C. Kirkbride, Kelly J. Gordon, Jason D. Lee, Nadine Hempel, Patrick Kelly, Benjamin J. Moeller, Jeffrey R. Marks, Gerard C. Blobe - Journal of Clinical Investigation 2006 cited by 256

  19. Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia

    Authors: Hsiu‐Ni Kung, Jeffrey R. Marks, Jen‐Tsan Chi - PLoS Genetics 2011 cited by 279

  20. The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy

    Authors: Suzanne E. Wardell, Jeffrey R. Marks, Donald P. McDonnell - Biochemical Pharmacology 2011 cited by 141

  21. Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features

    Authors: Rui Hou, Lars J. Grimm, Maciej A. Mazurowski, Jeffrey R. Marks, Lorraine King, Carlo C. Maley, Thomas Lynch, Marja van Oirsouw, Keith D. Rogers, Nicholas Stone, Matthew Wallis, Jonas Teuwen, Jelle Wesseling, E. Shelley Hwang, Joseph Y. Lo - Radiology 2022 cited by 40

  22. RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence

    Authors: Chao‐Chieh Lin, Nathaniel W. Mabe, Yi-Tzu Lin, Wen‐Hsuan Yang, Xiaohu Tang, Lisa Hong, Tianai Sun, Jeremy Force, Jeffrey R. Marks, Tso‐Pang Yao, James V. Alvarez, Jen‐Tsan Chi - Cell Death and Differentiation 2020 cited by 57

  23. Digital PCR Modeling for Maximal Sensitivity, Dynamic Range and Measurement Precision

    Authors: Nivedita Majumdar, Thomas Wessel, Jeffrey R. Marks - PLoS ONE 2015 cited by 125

  24. The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer

    Authors: Kimberly J. Cocce, Jeff S. Jasper, Taylor K. Desautels, Logan J. Everett, Suzanne E. Wardell, Thomas Westerling, Robert Baldi, Tricia M. Wright, Kendall Tavares, Alex Y. Yllanes, Yeeun Bae, Jeremy T. Blitzer, Craig D. Logsdon, Daniel P. Rakiec, David A. Ruddy, Tiancong Jiang, Gloria Broadwater, Terry Hyslop, Allison Hall, Muriel Lainé, Linda Phung, Geoffrey L. Greene, Lesley‐Ann Martin, Sunil Pancholi, Mitch Dowsett, Simone Detre, Jeffrey R. Marks, Gregory E. Crawford, Myles Brown, John D. Norris, Ching‐yi Chang, Donald P. McDonnell - Cell Reports 2019 cited by 93